Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
50.5M
-
Number of holders
-
449
-
Total 13F shares, excl. options
-
43.5M
-
Shares change
-
-813K
-
Total reported value, excl. options
-
$7.52B
-
Value change
-
-$106M
-
Put/Call ratio
-
0.76
-
Number of buys
-
231
-
Number of sells
-
-189
-
Price
-
$174.35
Significant Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q2 2020
506 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q2 2020.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 449 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.5M shares
of 50.5M outstanding shares and own 86.23% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.13M shares), Copper Rock Capital Partners, LLC (4.3M shares), FMR LLC (1.95M shares), STATE STREET CORP (1.2M shares), RENAISSANCE TECHNOLOGIES LLC (1.03M shares), BROWN ADVISORY INC (987K shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (859K shares), FIL Ltd (819K shares), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (793K shares), and Epoch Investment Partners, Inc. (739K shares).
This table shows the top 449 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.